Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
EndoPredict®
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Myriad Genetics
Type:
Laboratory Developed Test
Related tests:
‹
BRACAnalysis CDx™ (28)
Myriad myChoice® CDx (19)
COLARIS AP®
COLARIS®
Counsyl Reliant™ Cancer Screen
Myriad myChoice® CDx Plus
Myriad myRisk® Hereditary Cancer
PANEXIA™
Precise™ Liquid
Precise™ MRD
Precise™ Tumor Molecular Profile Test
Prolaris®
TheraMap Test
BRACAnalysis CDx™ (28)
Myriad myChoice® CDx (19)
COLARIS AP®
COLARIS®
Counsyl Reliant™ Cancer Screen
Myriad myChoice® CDx Plus
Myriad myRisk® Hereditary Cancer
PANEXIA™
Precise™ Liquid
Precise™ MRD
Precise™ Tumor Molecular Profile Test
Prolaris®
TheraMap Test
›
Details
Evidence
News
Search handles
Search handles
Filter by
Latest
3years
Endopredict 8 years follow up data . Predictive level is maintained irrespective of KI67 level and menopausal status . Is ki67 really Predictive marker for chemo? 🤔 #sabcs22 @OncoAlert @oncology_bg ()
3 years ago
EndoPredict®
over5years
#GermanFederalJointCommittee (G-BA) Issues Nationwide Reimbursement Decision for #EndoPredict® #BreastCancer Prognostic Test $MYGN https://t.co/ZVVmOvrGxc (@1stOncology)
over 5 years ago
Reimbursement • Prognostic test
|
EndoPredict®
7years
"Results for EndoPredict, Oncotype DX compared at #SABCS18 https://t.co/izWpcjaIhC via @AJMC_Journal" (@BCsurgstories)
7 years ago
EndoPredict®
Share
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.